Author:
Doroshow Deborah B.,Wei Wei,Gupta Swati,Zugazagoitia Jon,Robbins Charles,Adamson Blythe,Rimm David L.
Funder
National Cancer Institute
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference12 articles.
1. Immunotherapy in non-small cell lung cancer: facts and hopes;Doroshow;Clin Cancer Res,2019
2. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer;Brahmer;N Engl J Med,2015
3. Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer;Borghaei;N Engl J Med,2015
4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
5. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献